Rapamycin reduced pulmonary vascular remodelling by inhibiting cell proliferation via Akt/mTOR signalling pathway down-regulation in the carotid artery–jugular vein shunt pulmonary hypertension rat model

Ellagic acid prevents monocrotaline-induced pulmonary artery hypertension via inhibiting NLRP3 inflammasome activation in rats

(2015) Bing Tang et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

mTOR and vascular remodeling in lung diseases: current challenges and therapeutic prospects

(2013) Elena A. Goncharova   FASEB JOURNAL

mTOR Signaling in Growth Control and Disease

(2012) Mathieu Laplante et al.   CELL

Targeting mTOR Pathways in Human Malignancies

(2012) Angelica Fasolo et al.   CURRENT PHARMACEUTICAL DESIGN

Simvastatin attenuates pulmonary vascular remodelling by down-regulating matrix metalloproteinase-1 and -9 expression in a carotid artery-jugular vein shunt pulmonary hypertension model in rats

(2012) J. Yao et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

An evaluation of sirolimus in renal transplantation

(2012) Fabian Halleck et al.   Expert Opinion on Drug Metabolism & Toxicology

Sirolimus-Eluting Stents for Treatment of Infrapopliteal Arteries Reduce Clinical Event Rate Compared to Bare-Metal Stents

(2012) Aljoscha Rastan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular Disease and mTOR Signaling

(2012) Zhao Zhong Chong et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Effects of Everolimus in Combination with Sildenafil in Monocrotaline-induced Pulmonary Hypertension in Rats

(2011) Sinem Ilgin et al.   Cardiovascular Toxicology

Mechanisms of disease: pulmonary arterial hypertension

(2011) Ralph T. Schermuly et al.   Nature Reviews Cardiology

5-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation

(2009) Adriano Caixeta et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cellular and Molecular Basis of Pulmonary Arterial Hypertension

(2009) Nicholas W. Morrell et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger???s Syndrome

(2008) Nazzareno Galie et al.   DRUGS

Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy

(2008) Konstantinos Dimopoulos et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR−/− mice despite severe hypercholesterolemia

(2007) Marc A. Mueller et al.   ATHEROSCLEROSIS